Table 3.
Intraoperative and Postoperative Outcomes
| Parameter | Total (n = 180) | LithoVue (n = 115) | Reusable ureteroscope (n = 65) | p-value |
|---|---|---|---|---|
| All cases | ||||
| Scope failure | 10 (5.6%) | 5 (4.4%) | 5 (7.7%) | 0.27 |
| Presence of postoperative complications | 18 (10.0%) | 9 (7.8%) | 9 (13.8%) | 0.20 |
| Parameter | Total (n = 142) | LithoVue (n = 92) | Reusable ureteroscope (n = 50) | p-value |
|---|---|---|---|---|
| Case performed for stone removal | ||||
| Lithotriptor device, n (%) | ||||
| Laser lithotripsy and basket | 117 (82.4%) | 74 (80.4%) | 43 (86.0%) | 0.21 |
| Basket only | 22 (15.5%) | 17 (18.5%) | 5 (10.0%) | |
| No lithotrite | 1 (0.7%) | 0 | 1 (2.0%) | |
| Missing data | 2 (1.4%) | 1 (1.1%) | 1 (2.0%) | |
| Stone-free status, n (%) | ||||
| Stone free | 41 (52.6%) | 24 (60.0%) | 17 (44.7%) | 0.36 |
| Insignificant residual fragment | 10 (12.8%) | 5 (12.5%) | 5 (13.2%) | |
| Significant residual fragment | 27 (34.6%) | 11 (27.5%) | 16 (42.1%) | |
| Presence of postoperative complications | 14 (9.9%) | 5 (5.4%) | 9 (18.0%) | <0.05 |
| Primary stone composition, n (%) | ||||
| Calcium oxalate | 75 (52.8%) | 75 (47.8%) | 31 (62.0%) | 0.11 |
| Calcium carbonate | 13 (9.2%) | 7 (7.6%) | 6 (12.0%) | |
| Calcium phosphate | 2 (1.4%) | 0 | 2 (4.0%) | |
| Uric acid | 10 (7.0%) | 8 (8.7%) | 2 (4.0%) | |
| Struvite | 5 (3.5%) | 5 (5.4%) | 0 | |
| Cystine | 2 (1.4%) | 2 (2.2%) | 0 | |
| Other | 1 (0.7%) | 1 (1.1%) | 0 | |